Pfizer Inc. (PFE)

Pfizer Inc. (PFE) is a healthcare company (drug manufacturers - general) based in the United States. The share price is $28.54, down 1.11% on the day, which values the company at $162.67B. Price as of 17 Nov 2026, 17:14 UTC, from Yahoo Finance.

Key facts

Share price
$28.54−1.11% today
Market value
$162.67B
P/E ratio
40.8×last 12 months
Forward P/E
9.7×
Dividend yield
7.45%
Funk Score
40/100
Against its own history
About its usual priceusual price $29.93
200-week average
$28.881% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Pfizer Inc. in more detail

PFE trades at 40.8× its last twelve months' earnings, 9.7× next year's expected earnings, 2.6× sales. Measured against its own history, the price is 5% below what its usual multiples would imply ($29.93) — about its usual price. It sits 1% below its 200-week average of $28.88.

Over the last five fiscal years Pfizer Inc. has compounded revenue 8.5% a year, earnings per share -3.6% a year, free cash flow -5.7% a year. Its Funk Score is 40 out of 100 (financial strength 4.2, profitability 6.1, growth 2.2, value 3.4, each out of 10).

Worth checking: Dividend is not covered by free cash flow.

11 of the superinvestors tracked here hold PFE, including Thomas Kahn (1.9% of the portfolio), Mark Boyar (1.6% of the portfolio), Prem Watsa (1.5% of the portfolio).

Superinvestors holding PFE

11 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:PFE vs DHR (Pfizer Inc. vs Danaher)PFE vs ISRG (Pfizer Inc. vs Intuitive Surgical)PFE vs NVO (Pfizer Inc. vs Novo Nordisk)PFE vs ABT (Pfizer Inc. vs Abbott Laboratories)PFE vs VRTX (Pfizer Inc. vs Vertex Pharmaceuticals)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Pfizer Inc. (PFE): questions and answers

What is PFE's P/E ratio?

Pfizer Inc. trades at 40.8× its last twelve months' earnings and 9.7× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 9.4× to 77.8×, with a median of 17.2×.

What is PFE's PEG ratio?

Pfizer Inc.'s PEG ratio is 8.83 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Pfizer Inc.'s market cap?

Pfizer Inc. is valued at $162.67B at a share price of $28.54.

Is PFE overvalued or undervalued?

Against its own history, PFE is about its usual price: the price is 5% below the $29.93 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PFE above its 200-week moving average?

No. PFE is 1.2% below its 200-week average of $28.88. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Pfizer Inc. growing?

Over the last five fiscal years Pfizer Inc.'s revenue grew 8.5% a year and its earnings per share -3.6% a year; over ten years revenue grew 2.5% a year.

Cite this page

Funkfolio, “Pfizer Inc. (PFE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PFE

Underlying data: Yahoo Finance; company filings with the SEC.